- Forums
- ASX - By Stock
- RAC
- Ann: First Patient Safely Combine Dosed in Phase 1 RC220 Trial
RAC
race oncology ltd
Add to My Watchlist
4.27%
!
$1.22

Ann: First Patient Safely Combine Dosed in Phase 1 RC220 Trial, page-2
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.22 |
Change
0.050(4.27%) |
Mkt cap ! $203.2M |
Open | High | Low | Value | Volume |
$1.20 | $1.22 | $1.20 | $10.49K | 8.701K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 22243 | $1.20 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.22 | 868 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 22243 | 1.200 |
1 | 10 | 1.195 |
1 | 1531 | 1.185 |
2 | 4000 | 1.180 |
2 | 5430 | 1.170 |
Price($) | Vol. | No. |
---|---|---|
1.220 | 1368 | 2 |
1.225 | 7791 | 1 |
1.230 | 2605 | 2 |
1.250 | 4319 | 2 |
1.280 | 4060 | 1 |
Last trade - 10.17am 02/07/2025 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
RAC
RACE ONCOLOGY LTD
Dr Pete Smith, Executive Chairman
Dr Pete Smith
Executive Chairman
Previous Video
Next Video
SPONSORED BY The Market Online